Randomised comparison of silicone versus Teflon cannulas for peripheral intravenous nutrition.

Por Reynolds, J. V., Walsh, K., Ruigrok, J., Hyland, J. M.
Publicado em 1995

P53 abnormalities and outcomes in colorectal cancer: a systematic review

Por Smith, F M, Stephens, R B, Kennedy, M J, Reynolds, J V
Publicado em 2005

Necrotising pancreatitis presenting as a painful mass in the groin and sepsis

Por O'Sullivan, K E, Larkin, J O, Guiney, M, Reynolds, J V
Publicado em 2013

Curative surgical management of isolated adrenal recurrence of oesophageal adenocarcinoma

Por O'Sullivan, K E, Moriarty, A R, Larkin, J O, Reynolds, J V
Publicado em 2013

Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts.

Por Reynolds, J V, Daly, J M, Shou, J, Sigal, R, Ziegler, M M, Naji, A
Publicado em 1990

Spontaneous and inducible apoptosis in oesophageal adenocarcinoma

Por Raouf, A, Evoy, D, Carton, E, Mulligan, E, Griffin, M, Sweeney, E, Reynolds, J V
Publicado em 2001

High-dose interleukin 2 promotes bacterial translocation from the gut.

Por Reynolds, J. V., Murchan, P., Leonard, N., Gough, D. B., Clarke, P., Keane, F. B., Tanner, W. A.
Publicado em 1995

A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma

Por Ryan, B M, McManus, R, Daly, J S, Carton, E, Keeling, P W N, Reynolds, J V, Kelleher, D
Publicado em 2001

Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up

Por Mahmood, Z, McMahon, B P, Arfin, Q, Byrne, P J, Reynolds, J V, Murphy, E M, Weir, D G
Publicado em 2003

Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery

Por Byrne, M, Reynolds, J V, O'Donnell, J S, Keogan, M, White, B, Byrne, M, Murphy, S, Maher, S G, Pidgeon, G P
Publicado em 2010

Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice.

Por Welsh, F K, Ramsden, C W, MacLennan, K, Sheridan, M B, Barclay, G R, Guillou, P J, Reynolds, J V
Publicado em 1998

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response

Por Gillham, C M, Lucey, J A, Keogan, M, Duffy, G J, Malik, V, Raouf, A A, O'Byrne, K, Hollywood, D, Muldoon, C, Reynolds, J V
Publicado em 2006

Changes in mitochondrial stability during the progression of the Barrett’s esophagus disease sequence

Por O’Farrell, N. J., Feighery, R., Picardo, S. L., Lynam-Lennon, N., Biniecka, M., McGarrigle, S. A., Phelan, J. J., MacCarthy, F., O’Toole, D., Fox, E. J., Ravi, N., Reynolds, J. V., O’Sullivan, J.
Publicado no BMC Cancer (2016)

Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study

Por Markar, S. R., Noordman, B. J., Mackenzie, H., Findlay, J. M., Boshier, P. R., Ni, M., Steyerberg, E. W., van der Gaast, A., Hulshof, M. C. C. M., Maynard, N., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., Reynolds, J. V., Van Lanschot, J. J. B., Hanna, G. B.
Publicado no Ann Oncol (2017)